In contrast, infection of the Beta variant elicited high titers of spike-binding and neutralizing antibodies against both the prototype and gamma variant, indicating Beta spike protein as a promising candidate for inducing cross-reactive neutralizing antibody responses to SARS-CoV-2 [21]. This evidence concerns the gene PROS1 and infection.